z-logo
Premium
Radioimmunoassay Inhibition Method for Confirming the Specificity of Positive Hepatitis B Surface Antigen Reactions and for Survey of Antibodies to the Antigen 1
Author(s) -
Forghani Bagher,
Schmidt Nathalie J.,
Lennette Edwin H.
Publication year - 1977
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/j.1423-0410.1977.tb00616.x
Subject(s) - radioimmunoassay , hbsag , antigen , antibody , antiserum , titer , heterologous , virology , hepatitis b , microbiology and biotechnology , chemistry , biology , immunology , hepatitis b virus , virus , biochemistry , gene
. Studies were conducted to determine the hepatitis B surface antigen antibody (anti‐HB S ) levels and antibody subtype specificities required in order for anti‐HB S sera of human origin to be suitable for use in radioimmunoassay (RIA) inhibition tests for determining the specificity of positive reactions for hepatitis B surface antigen (HB S Ag.) Also, the RIA inhibition method was evaluated for detection of anti‐HB S in sera of laboratory personnel. Only anti‐HB S sera with complement‐fixing (CF) antibody titers of 1:32 or higher effectively inhibited HB S Ag‐positive sera with demonstrable CF activity, and complete inhibition was obtained only for antigens having CF titers of 1:64 or lower. Higher‐titered antigens could be inhibited when diluted 1:10‐1: 100. The low‐titered HB S Ag preparation supplied with AusRIA kits (Abbott Laboratories) was effectively inhibited by low‐titered anti‐HB S sera, and when used in RIA inhibition tests on sera from laboratory personnel, the tests detected anti‐HB S in approximately 14% of the individuals tested, a slightly greater number than those showing anti‐HB s in passive hemagglutination tests. Inhibition of HB S Ag‐positive sera by the anti‐HB S sera could not be related to the d and y subtype specificities of the antigens or antisera; the antisera were no more effective in inhibiting antigens of the homologous subtype than those of the heterologous subtype.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here